We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+8.89%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$6.73M
Cap. Flow
-$1.03M
Cap. Flow %
-0.79%
Top 10 Hldgs %
28.35%
Holding
135
New
27
Increased
31
Reduced
39
Closed
22

Top Buys

Rank Stock Value
1
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
+$9.2M
2
ALLK
Allakos
ALLK
+$3.62M
3
TSM icon
TSMC
TSM
+$1.56M
4
LKQ icon
LKQ Corp
LKQ
+$1.2M
5
DBX icon
Dropbox
DBX
+$1M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.37M
2
HOLX
Hologic
HOLX
+$1.35M
3
TWTR
Twitter, Inc.
TWTR
+$1.34M
4
BAX icon
Baxter International
BAX
+$1.29M
5
CNC icon
Centene
CNC
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 49.05%
2 Technology 17.83%
3 Communication Services 7.12%
4 Consumer Discretionary 3.23%
5 Financials 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSII
76
DELISTED
Cardiovascular Systems, Inc.
CSII
$437K 0.33%
11,167
-162
-1% -$5.99K
ACOR
77
CALL
DELISTED
Acorda Therapeutics
ACOR
$411K 0.31%
+174
New +$539K
GRUB
78
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$403K 0.31%
+1,452
New +$375K
CI icon
79
Cigna
CI
$74.6B
$356K 0.27%
+1,709
New +$317K
ELAN icon
80
Elanco Animal Health
ELAN
$11.1B
$332K 0.25%
+9,518
New +$335K
SLDB icon
81
Solid Biosciences
SLDB
$900M
$312K 0.24%
440
+189
+75% +$119K
ACOR
82
DELISTED
Acorda Therapeutics
ACOR
$305K 0.23%
129
-102
-44% -$316K
SRPT icon
83
Sarepta Therapeutics
SRPT
$1.77B
$282K 0.22%
+1,748
New +$239K
WMGI
84
DELISTED
Wright Medical Group Inc
WMGI
$282K 0.22%
+9,718
New +$262K
ALDR
85
DELISTED
Alder Biopharmaceuticals
ALDR
$265K 0.2%
15,886
-7,910
-33% -$143K
CLVS
86
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$264K 0.2%
9,000
– –
SNNA
87
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$226K 0.17%
15,283
-2,060
-12% -$32.7K
IRTC icon
88
iRhythm Holdings
IRTC
$4.2B
$218K 0.17%
2,303
-2,984
-56% -$260K
FATE icon
89
Fate Therapeutics
FATE
$326M
$202K 0.15%
+12,387
New +$146K
KURA icon
90
Kura Oncology
KURA
$850M
$176K 0.13%
10,072
-188
-2% -$3.6K
GRTS
91
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$165K 0.13%
+13,092
New +$186K
ELGX
92
DELISTED
Endologix Inc
ELGX
$152K 0.12%
7,977
-431
-5% -$15.4K
TENB icon
93
Tenable Holdings
TENB
$4.01B
$145K 0.11%
+3,717
New +$124K
ARAY icon
94
Accuray
ARAY
$34M
$142K 0.11%
31,513
-10,755
-25% -$42.4K
MDB icon
95
MongoDB
MDB
$32.1B
$133K 0.1%
+1,637
New +$109K
CBLK
96
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$131K 0.1%
6,163
– –
MRNS
97
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$112K 0.09%
+2,797
New +$79.6K
VRAY
98
DELISTED
ViewRay, Inc.
VRAY
$80K 0.06%
+8,597
New +$84.5K
RCUS icon
99
Arcus Biosciences
RCUS
$3.64B
$72K 0.06%
5,161
-96
-2% -$1.22K
AUTL
100
Autolus Therapeutics
AUTL
$562M
$64K 0.05%
2,094
-32
-2% -$864
2 3
4
5 6

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, Partner Investment Management held 135 positions worth $131M, up 5.4% from $124M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Partner Investment Management's Q3 2018 filing shows 27 new, 31 increased, 39 reduced and 22 closed positions. Its largest new stake was Allakos: 88,125 shares worth $3.54M. The largest sale was Baidu, an estimated $2.37M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q3 2018 buy was Allakos: 88,125 shares worth $3.54M.
  • Partner Investment Management added most to Neon Therapeutics, Inc. Common Stock in Q3 2018, an estimated $9.2M increase.
  • Partner Investment Management's biggest Q3 2018 reduction was Elevance Health, cutting an estimated $1.02M.
  • Partner Investment Management fully exited Baidu in Q3 2018, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 28% of its $131M portfolio in Q3 2018.
  • Partner Investment Management opened 27 new positions and closed 22 in Q3 2018.
  • Partner Investment Management's portfolio value rose 5.4% quarter-over-quarter to $131M.

Based on Partner Investment Management's 13F filing for Q3 2018, filed 13 Nov 2018.